Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 3, 2026.

The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable?

Arnold F. Kaufmann, Martin I. Meltzer, G P Schmid

Emerging Infectious Diseases · 1997 · Review

doi:10.3201/eid0302.970201

Abstract

Understanding and quantifying the impact of a bioterrorist attack are essential in developing public health preparedness for such an attack. We constructed a model that compares the impact of three classic agents of biologic warfare (Bacillus anthracis, Brucella melitensis, and Francisella tularensis) when released as aerosols in the suburb of a major city. The model shows that the economic impact of a bioterrorist attack can range from an estimated $477.7 million per 100,000 persons exposed (brucellosis scenario) to $26.2 billion per 100,000 persons exposed (anthrax scenario). Rapid implementation of a postattack prophylaxis program is the single most important means of reducing these losses. By using an insurance analogy, our model provides economic justification for preparedness measures.

References 13

  1. 1.

    Abramova F. A., Grinberg L. M., Yampolskaya O. V., Walker D. H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90(6):2291-2294.

    Not in our library10.1073/pnas.90.6.2291

  2. 2.

    Cole L. A. The specter of biological weapons. Sci Am. 1996;275(6):60-65.

    Not in our library10.1038/scientificamerican1296-60

  3. 3.

    Friedlander A. M., Welkos S. L., Pitt M. L., Ezzell J. W., Worsham P. L., Rose K. J., Ivins B. E., Lowe J. R., Howe G. B., Mikesell P. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993;167(5):1239-1243.

    Not in our library10.1093/infdis/167.5.1239

  4. 4.

    GOCHENOUR W. S. Aerobiology. Mil Med. 1963;128:86-89.

    Not in our library

  5. 5.

    Kaufmann A. F., Fox M. D., Boyce J. M., Anderson D. C., Potter M. E., Martone W. J., Patton C. M. Airborne spread of brucellosis. Ann N Y Acad Sci. 1980;353:105-114.

    Not in our library10.1111/j.1749-6632.1980.tb18912.x

  6. 6.

    McCrumb F. R. AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS. Bacteriol Rev. 1961;25(3):262-267.

    Not in our library10.1128/br.25.3.262-267.1961

  7. 7.

    Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A., Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266(5188):1202-1208.

    Not in our library10.1126/science.7973702

  8. 8.

    Ollé-Goig J. E., Canela-Soler J. An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. Am J Public Health. 1987;77(3):335-338.

    Not in our library10.2105/ajph.77.3.335

  9. 9.

    SASLAW S., EIGELSBACH H. T., WILSON H. E., PRIOR J. A., CARHART S. Tularemia vaccine study. I. Intracutaneous challenge. Arch Intern Med. 1961;107:689-701.

    Not in our library10.1001/archinte.1961.03620050055006

  10. 10.

    Sawyer W. D., Dangerfield H. G., Hogge A. L., Crozier D. Antibiotic prophylaxis and therapy of airborne tularemia. Bacteriol Rev. 1966;30(3):542-550.

    Not in our library10.1128/br.30.3.542-550.1966

  11. 11.

    Solera J., Rodríguez-Zapata M., Geijo P., Largo J., Paulino J., Sáez L., Martínez-Alfaro E., Sánchez L., Sepulveda M. A., Ruiz-Ribó M. D. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Chemother. 1995;39(9):2061-2067.

    Not in our library10.1128/aac.39.9.2061

  12. 12.

    Staszkiewicz J., Lewis C. M., Colville J., Zervos M., Band J. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol. 1991;29(2):287-290.

    Not in our library10.1128/jcm.29.2.287-290.1991

  13. 13.

    TREVER R. W., CLUFF L. E., PEELER R. N., BENNETT I. L. Brucellosis. I. Laboratory-acquired acute infection. AMA Arch Intern Med. 1959;103(3):381-397.

    Not in our library10.1001/archinte.1959.00270030037004

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.